Latest period
$66.63B
YoY change
+3.5%
5Y CAGR
+5.0%
Peak year (2021)
$66.08B
Latest annual
$65.36B
Total Liabilities history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: $65.36B
Total Liabilities growth chart for AstraZeneca (AZN) from 1990 to 2025
Latest: +3.5%
Total Liabilities history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | $65.36B | +3.5% | +$2.19B | ||
| 2024 | $63.16B | +2.0% | +$1.21B | ||
| 2023 | $61.95B | +4.3% | +$2.53B | ||
| 2022 | $59.42B | -10.1% | −$6.65B | ||
| 2021 | $66.08B | +29.3% | +$14.98B | ||
| 2020 | $51.09B | +9.2% | +$4.31B | ||
| 2019 | $46.78B | +0.4% | +$174.00M | ||
| 2018 | $46.61B | -0.2% | −$105.00M | ||
| 2017 | $46.71B | +1.9% | +$855.00M | ||
| 2016 | $45.86B | +10.2% | +$4.24B | ||
| 2015 | $41.62B | +6.8% | +$2.67B | ||
| 2014 | $38.95B | +19.3% | +$6.30B | ||
| 2013 | $32.65B | +10.4% | +$3.06B | ||
| 2012 | $29.58B | +0.8% | +$224.00M | ||
| 2011 | $29.36B | -10.3% | −$3.36B | ||
| 2010 | $32.72B | -4.1% | −$1.38B | ||
| 2009 | $34.10B | +10.4% | +$3.21B | ||
| 2008 | $30.89B | -6.5% | −$2.15B | ||
| 2007 | $33.04B | +127.6% | +$18.53B | ||
| 2006 | $14.52B | +30.2% | +$3.37B | ||
| 2005 | $11.15B | -0.1% | −$6.00M | ||
| 2004 | $11.15B | +8.1% | +$839.00M | ||
| 2003 | $10.32B | -0.3% | −$34.00M | ||
| 2002 | $10.35B | -18.4% | −$2.33B | ||
| 2001 | $12.68B | +42.5% | +$3.78B | ||
| 2000 | $8.90B | -6.0% | −$571.92M | ||
| 1999 | $9.47B | +99.2% | +$4.72B | ||
| 1998 | $4.75B | +2.0% | +$95.45M | ||
| 1997 | $4.66B | -5.0% | −$242.72M | ||
| 1996 | $4.90B | +1.4% | +$67.76M | ||
| 1995 | $4.83B | +5.2% | +$240.15M | ||
| 1994 | $4.59B | -9.9% | −$507.01M | ||
| 1993 | $5.10B | -15.3% | −$917.94M | ||
| 1992 | $6.02B | +10.5% | +$573.08M | ||
| 1991 | $5.45B | +0.5% | +$26.77M | ||
| 1990 | $5.42B | — | — |
- 2025$65.36B+3.5%
- 2024$63.16B+2.0%
- 2023$61.95B+4.3%
- 2022$59.42B-10.1%
- 2021$66.08B+29.3%
- 2020$51.09B+9.2%
- 2019$46.78B+0.4%
- 2018$46.61B-0.2%
- 2017$46.71B+1.9%
- 2016$45.86B+10.2%
- 2015$41.62B+6.8%
- 2014$38.95B+19.3%
- 2013$32.65B+10.4%
- 2012$29.58B+0.8%
- 2011$29.36B-10.3%
- 2010$32.72B-4.1%
- 2009$34.10B+10.4%
- 2008$30.89B-6.5%
- 2007$33.04B+127.6%
- 2006$14.52B+30.2%
- 2005$11.15B-0.1%
- 2004$11.15B+8.1%
- 2003$10.32B-0.3%
- 2002$10.35B-18.4%
- 2001$12.68B+42.5%
- 2000$8.90B-6.0%
- 1999$9.47B+99.2%
- 1998$4.75B+2.0%
- 1997$4.66B-5.0%
- 1996$4.90B+1.4%
- 1995$4.83B+5.2%
- 1994$4.59B-9.9%
- 1993$5.10B-15.3%
- 1992$6.02B+10.5%
- 1991$5.45B+0.5%
- 1990$5.42B—
Total Liabilities values are taken from AstraZeneca's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported total liabilities is $66.63B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, AstraZeneca (AZN) reported total liabilities of $65.36B – edged up 3.5% year-over-year.
AstraZeneca total liabilities has grown on net over the period, with a +5.0% compound annual growth rate over 2020–2025 (5 years).
$66.08B stands as the all-time-high annual total liabilities, posted in 2021, against a low of $4.59B during 1994.
AstraZeneca Total Liabilities by Year
AstraZeneca Total Liabilities 2025: $65.36B
AstraZeneca posted total liabilities of $65.36B in 2025, edged up 3.5% from 2024.
AstraZeneca Total Liabilities 2024: $63.16B
In 2024, AstraZeneca reported total liabilities of $63.16B, edged up 2.0% from 2023.
AstraZeneca Total Liabilities 2023: $61.95B
AstraZeneca total liabilities in 2023 was $61.95B, edged up 4.3% from 2022.
AstraZeneca Total Liabilities 2022: $59.42B
2022's total liabilities for AstraZeneca came in at $59.42B, declined 10.1% below 2021.
AstraZeneca Total Liabilities 2021: $66.08B
AstraZeneca total liabilities in 2021 was $66.08B.
See more financial history for AstraZeneca (AZN).
Sector peers by Total Liabilities
Healthcare peers of AstraZeneca (AZN), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $56.81B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $54.86B
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation